Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Genmab (NASDAQ:GMAB) to Acquire Merus (NASDAQ:MRUS) in USD 8B All-Cash Transaction

Genmab A/S (NASDAQ:GMAB) and Merus N.V. (NASDAQ:MRUS) have signed an agreement under which Genmab will acquire all outstanding Merus shares in an all-cash deal at USD 97 per share, representing a total transaction value of roughly USD 8B. The deal has secured the Boards …

Team Kalkine | 29 September 2025

Daily Market Brief: U.S. Budget Standoff, Tariff Plans, Commodity Swings, and Futures Outlook

Focus remains on U.S. budget talks, with President Trump meeting congressional leaders today to avert a government shutdown set to begin midweek without a funding deal. Premarket trading showed most megacaps higher—Amazon (+1.2%), Alphabet (+1.1%), Nvidia (+0.7%), Meta (+0.8%), Microsoft (+0.3%), and Broadcom (+0.9%)—while …

Team Kalkine | 29 September 2025

Treasure Global (NASDAQ:TGL) Appoints Michael Chan as Executive Director

Treasure Global Inc. (NASDAQ:TGL) announced the appointment of Michael Chan as an Executive Director of its Board of Directors, effective immediately.

Team Kalkine | 29 September 2025

Sunrise New Energy (NASDAQ:EPOW) Launches 1GW U.S. Lithium Battery Pack Project

Sunrise New Energy Co., Ltd. (NASDAQ:EPOW) announced plans to establish a 1GW lithium battery pack project in the United States through its newly formed U.S. subsidiary, Alchemistica Incorporated. The initiative targets the expanding demand for energy storage batteries across North America, including residential and …

Team Kalkine | 29 September 2025

GitLab (NASDAQ:GTLB) Named Leader in 2025 Gartner Magic Quadrant for DevOps Platforms

GitLab Inc. (NASDAQ:GTLB) has been named a Leader in the 2025 Gartner Magic Quadrant for DevOps Platforms. The evaluation considered 10 vendors and builds on GitLab’s recent recognition as a Leader in the Gartner Magic Quadrant for AI Code Assistants. This marks the third …

Team Kalkine | 29 September 2025

Autolus Therapeutics (NASDAQ:AUTL)  Shares Attract Positive Analyst Ratings Amid Volatility

William Blair reiterated its outperform rating on Autolus Therapeutics (NASDAQ:AUTL), reinforcing a broadly positive analyst sentiment for the clinical-stage biotech firm. Needham & Company echoed this view with a “buy” rating and a USD 10.00 price target, while Wells Fargo trimmed its target to …

Aditi Sarkar | 28 September 2025

First Commonwealth Financial Corporation (NYSE:FCF) Boosts Dividend, Approves USD 25Mn Share Buyback

First Commonwealth Financial Corporation (NYSE:FCF)operates as a financial holding company. Its subsidiaries include First Commonwealth Bank (FCB), First Commonwealth Insurance Agency, Inc. (FCIA), and FRAMAL. Through FCB, the company offers a broad range of consumer and commercial banking services.

Aditi Sarkar | 26 September 2025

Organogenesis (Nasdaq:ORGO) Reports Update on Second Phase 3 ReNu® Trial

Organogenesis Holdings Inc. (Nasdaq:ORGO) announced an update on its second Phase 3 randomized controlled trial (RCT) of ReNu®, a cryopreserved amniotic suspension allograft (ASA) for symptomatic knee osteoarthritis (OA). While the study did not achieve statistical significance for its primary endpoint, the results showed …

Team Kalkine | 26 September 2025

TC Properties (NYSE:LTC) Advances External Growth Strategy With 40M USD SHOP Acquisition

LTC Properties, Inc. (NYSE:LTC), a real estate investment trust focused on seniors housing and health care properties, announced the closing of a 40M USD Senior Housing Operating Portfolio acquisition. The purchase includes two assisted living and memory care communities in Kentucky totaling 158 units.

Team Kalkine | 26 September 2025

Global Markets Weekly Update: Inflation, Tariffs, and Fed Policy in Focus

Markets are awaiting key inflation data that could guide the Fed’s next moves, after strong GDP and lower jobless claims slightly dampened hopes for aggressive rate cuts. Investors still expect 25 bps cuts in both October and December. On trade, President Trump unveiled steep …

Team Kalkine | 26 September 2025
Support

Hi! How can we help you today?

Loading…